SYNGEN (8279.TWO) monthly revenue, September 2026
SYNGEN reported revenue of NT$0.20bn for September 2026, up 12.7% from the previous month and down 7.8% from a year earlier. Year-to-date revenue was NT$1.57bn, down 5.3% year on year. It ranked 120 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.20 | 12.7 | -7.8 |